In forecasting the future of cardiovascular disease (CVD), the American Heart Association calls for preventive strategies, with particular attention to obesity.1 The facts related to the current obesity epidemic are familiar, stark, and bode bad news not only for the physical health of the US population but also for its economic health. Obesity is a common denominator in and a risk factor for many chronic conditions, including diabetes, coronary artery disease (CAD), stroke, and hypertension.2,3
Employers’ Obesity Initiatives in the Workplace: A Wakeup Call for Health Plans
Robert Lee Page ii, PharmD, MSPH, FAHA, FCCP, FASCcP, FASHP, BCPS, Vahram Ghushchyan, PhD, Kavita Nair, PhD
Despite advances in life-saving medical interventions and pharmacotherapies, cardiovascular disease (CVD) continues to be a leading killer in the United States.1 The spectrum of CVD consists of hypertension, chronic heart disease (CHD; including myocardial infarction [MI] and angina), heart failure, and stroke.
Prevention Efforts before Disease Strikes the Key to a Healthy Population of Young Adults
Atypical Antipsychotics and Metabolic Syndrome in Patients with Schizophrenia: Risk Factors, Monitoring, and Healthcare Implications
Karmella T. Thomas, BS, RD, Katie B. Lyons, MS II, Loida D. Nguyen, PharmD, BCPS, Raymond A. Plodkowski, MD, Quang T. Nguyen, DO, FACP, FACE, FTOS
Diabetes is the leading cause of kidney failure, nontraumatic lower-limb amputations, and new cases of blindness among adults in the United States.
New Therapies with Novel Mechanisms of Action Are Urgently Needed for Type 2 Diabetes
The prevalence of diabetes has increased dramatically in recent decades. This trend highlights the importance of prevention and appropriate therapy to reduce cardiovascular events in patients with diabetes. Reaching adequate blood glucose control is important in decreasing microvascular complications associated with diabetes; however, good lipid management is vital for reducing the incidence of cardiovascular events in patients with diabetes.1-4
The Time Is Now to Promote Aggressive Lipid Management to Prevent Macrovascular Complications in Patients with Type 2 Diabetes
Results 1 - 6 of 6